SQUIRE PATTON BOGGS for PFIZER INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
American Recovery and Reinvestment Act (PL 111-5); Promoting Innovation and Access to Life-Saving Medicine Act (HR 1427/S 726); Pathway for Biosimilars Act (HR 1548); Patient-Centered Outcomes Research Act of 2009 (S 1213); Comparative Effectiveness Research Act of 2009 (HR 2502); Doctor-Patient Relationship and Research Protection Act (HR 2824); Protecting Consumer Access to Generic Drugs Act of 2009 (HR 1706); Food and Drug Administration Globalization Act of 2009 (HR 759); Drug and Device Accountability Act of 2009 (S 882); Pharmaceutical Market Access and Drug Safety Act of 2009 (HR 1298/S 1232)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| MATTHEW TODD TUTEN | — |
Medicare/Medicaid MMM
Medicare Prescription Drug Savings and Choice Act (S333/HR 684); Medicaid Prescription Drug Rebate Equalization Act of 2009 (HR 904); Drug Rebate Equalization Act of 2009 (S 547); Voluntary State Discount Prescription Drug Plan Act of 2009 (HR 1725); Affordable Health Care Choices Act (no # yet)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| MATTHEW TODD TUTEN | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to possible merger of Pfizer and Wyeth
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN YAROWSKY | GCHouseJudCom82-95; SACPres95-98 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.